CGEM
Cullinan Therapeutics Inc (formerly Cullinan Oncology Inc)
Clinical-stage biopharmaceutical company developing therapies for autoimmune diseases and cancer in the United States
CUSIP: 230031106HealthcareUS1 holder
Total Value
$5.51M
Total Shares
429.6K
Net Share Change
-1.11M
Activity
1 selling
Investor
Value
Shares
Weight
Change
Baupost Group LLC
$5.51M429.6K shares
TRIM-1.11M(-72.0%)